CellabMED: Clinical Trials

3 trials sponsored by CellabMED, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Unknown 1
Phase 21Completed 1

Follow CellabMED: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study of IL13Rα2 Targeted CAR-T in Patients With Malignant Glioma (MAGIC-I)
YYB-103 - Recurrent Malignant Glioma
Phase 1UnknownCellabMED182022-07-182023-01-06
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients
YYB101 - Colorectal Cancer Metastatic, Colorectal Cancer Recurrent
Phase 1 / Phase 2CompletedCellabMED352019-08-092022-11-14
Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy
YYB101 - Solid Tumors
Phase 1CompletedCellabMED392015-07-132021-05-13

Conditions studied

Glioma (1)

Interventions

monoclonal antibody YYB-101 (2)

Countries

South Korea (3)

Top investigators

Garam Im (1)  ·  Hong SungHee, MS (1)  ·  Hoonkyo Kim, Ph.D (1)  ·  Kim Jung Yong, MD, Ph.D (1)

Results publications

PMID 32536979